Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The NHS rollout of the HIV-preventing drug regimen PrEP (pre-exposure prophylaxis) has been ‘indefinitely postponed’ due to the Covid-19 pandemic, according to .
PrEP is a daily tablet – sold by Gilead under the brand names Truvada and Descovy, with generics expected to hit the market later this year – which prevents those taking it from being able to contract HIV.
On 15 March, one week before the UK’s lockdown was imposed, it was announced that the government would be giving local authorities £16m across 2020 and 2021 to get the drug into routine commissioning across England.